Skip to main content
ENDO 2026 Main banner

Topic: Adipose Tissue_Appetite_and Obesity
Session Type: Plenary

PL06 - Post-Plenary Discussion: Molecular Mechanisms in Hormone Signaling: From Bench to Bedside

Monday, June 15, 2026
9:30 AM - 10:15 AM CT
Location: ENDOExpo; ENDO Booth

    Moderator(s)

  • RM

    Raghavendra Mirmira, MD, PhD

    The University of Chicago
    Chicago, Illinois, United States

    Disclosure information not submitted.

    • Plenary Speaker(s)

  • Barbara Kahn, MD

    Vice Chair for Research Strategy and Professor
    Beth Israel Deaconess Medical Center
    Boston, MA, United States

    Disclosure(s): Arrowhead Pharmaceuticals: Consultant (); Cantoni Therapeutics: Advisory Board (); Vida Ventures Advisors, LLC: Consultant ()

  • Daniel Drucker, MD

    Professor
    Mt Sinai Hospital
    Toronto, ON, Canada

    Disclosure(s): Abbvie, Amgen, AstraZeneca, Eli Lilly, General Medicines, Pfizer: Consultant (); Amgen, Eli Lilly, Zealand Pharma: Grant Recipient ()

Disclosure(s):
Barbara Kahn, MD: Arrowhead Pharmaceuticals: Consultant (); Cantoni Therapeutics: Advisory Board (); Vida Ventures Advisors, LLC: Consultant ()
Daniel Drucker, MD: Abbvie, Amgen, AstraZeneca, Eli Lilly, General Medicines, Pfizer: Consultant (); Amgen, Eli Lilly, Zealand Pharma: Grant Recipient ()

Following each plenary session, join a dynamic conversation with the speakers led by esteemed Endocrine Society members. This interactive session offers a unique opportunity to delve deeper into the cutting-edge research and clinical practice presented.


Ask questions, challenge assumptions, and engage in a lively exchange of ideas with the experts. Gain fresh perspectives and explore the future of research, discovery, and patient care.